Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$41.13 -0.08 (-0.21%)
As of: Oct 22, 2026 · 2:29 PM EDT

Supernus Pharmaceuticals (SUPN) Long-Term Debt Issuances (2011 - 2018)

Updated

Supernus Pharmaceuticals (SUPN) posted Long-Term Debt Issuances of $402.5 million for FY2018.

Analysis

Supernus Pharmaceuticals (SUPN) Long-Term Debt Issuances (2011 - 2018) Analysis & Trends

  • Annual Long-Term Debt Issuances shows a five-year compound annual growth rate of 34.9% (FY2013 to FY2018).
  • The FY2018 figure stands as the lowest annual Long-Term Debt Issuances since FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn -
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn -
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn -
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn -
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn -
10 Supernus Pharmaceuticals 2.39 Bn 1.05 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 402.50 Mn
Jun 30, 2013 86.50 Mn
Mar 31, 2011 15.00 Mn
API Access

Supernus Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=SUPN&period=max&api_key=YOUR_API_KEY